NEW YORK (Reuters Health) – Men 60 years old and younger have excellent quality-of-life outcomes after proton therapy for prostate cancer, according to findings published in the January 17th online issue of Cancer.
Proton therapy is a highly conformal radiotherapy that delivers much less radiation dose to...